Three cases of uncommon medication‐associated osteonecrosis of temporal bone

• Published in: World journal of otorhinolaryngology - head and neck surgery Vol. 10; no. 3; pp. 237 - 240
• Main Authors: VanDolah, Hunter, Crossley, Jason R., Kim, H. Jeffrey
• Format: Journal Article
• Language: English
• Published: United States John Wiley and Sons Inc 01.09.2024; Wiley
• Subjects: bisphosphonates; Case Study; denosumab; external auditory canal; imatinib; medication‐related osteonecrosis; osteonecrosis; temporal bone; tyrosine‐kinase Inhibitors; temporal bone; tyrosine‐kinase Inhibitors; imatinib; bisphosphonates; external auditory canal; osteonecrosis; medication‐related osteonecrosis; denosumab
• ISSN: 2095-8811; 2589-1081; 2589-1081
• DOI: 10.1002/wjo2.146

Introduction Medication‐related osteonecrosis of the temporal bone is rare and has been reported to be associated with the use of anti‐resorptive and biologic agents. Here, we present the first case of tyrosine‐kinase inhibitor‐related external auditory canal (EAC) osteonecrosis as well as two cases related to anti‐resorptive therapies. Methods A retrospective case series. Results Case one: an 84‐year‐old female presented with chronic otitis externa and osteonecrosis of EACs bilaterally. She had a history of osteoporosis treated with denosumab and risedronic acid. She successfully underwent left EAC reconstruction using an inferiorly‐based pedicle periosteal flap while the right ear canal was managed conservatively. Case two: a 69‐year‐old male presented with osteonecrosis of the right EAC. He had a history of osteoporosis treated with alendronic acid and zoledronic acid. His osteonecrosis is conservatively managed with local debridement and antibiotic application. Case three: a 60‐year‐old male presented with osteonecrosis of the right inferior EAC. He had a history of chronic myelogenous leukemia treated with a tyrosine‐kinase inhibitor, imatinib. After failing conservative therapy, he underwent right ear canal reconstruction using a periosteal vascular pedicle flap without complication and experienced complete resolution to his symptoms. Conclusion Anti‐resorptive agents and/or tyrosine kinase inhibitors may lead to dysregulation of bone remodeling and result in rare cases of temporal bone osteonecrosis. When a local debridement and antibiotic therapy fail, definitive surgical excision of necrotic bone with subsequent reconstruction of the EAC may offer patients a possible resolution in symptoms.